GALAXIES PHARMACEUTICALS OÜ

Media page and news feed
?
Attention! GALAXIES PHARMACEUTICALS OÜ has failed to meet its obligations and has ignored repeated requests from creditors. This behavior is a serious sign of t

GALAXIES PHARMACEUTICALS OÜ: Debt and Loss of Credibility

Liabilities

Liabilities

Credit risk forecasts, credit limits, debts, reportings, mortgages, court decisions and other precepts

See report >

Attention! GALAXIES PHARMACEUTICALS OÜ has failed to meet its obligations and has ignored repeated requests from creditors. This behavior is a serious sign of the company’s lack of cooperation and may pose a risk to future business partners.

📌 Total damage caused to creditors: 338,75 EUR.

The management of the company at the time of the debts included Fawzy Ali Saad, who started business in the business sector: Manufacture of basic pharmaceutical products   - 5 years ago at the age of 66. The total revenue of the companies managed by this individual in 2026 was 0.0 EUR.

Although Fawzy Ali Saad is currently operating in GALAXIES PHARMACEUTICALS OÜ, no quarterly revenue has been recorded there.

🔴 Inforegister recommends avoiding cooperation with GALAXIES PHARMACEUTICALS OÜ until the company has fulfilled its obligations and restored its credibility.

📢 Creditors, let’s make the business environment more transparent!

Publish your claims in the Inforegister, ensuring that companies that meet their obligations receive a fair competitive advantage.

🔗Publish your claim here

🔗Arrange a payment plan and restore your credibility

Comments (0)


Are you sure you want to delete this article?

Dropdown

all articles

Reliable sterile and scalable production of biological medicinal products

The production of biological medicines   requires precision, control and flexibility - every step must ensure safety and the stability of active substances. The
ssb.ee
The production of biological medicines requires precision, control and flexibility - every step must ensure safety and the stability of active substances. The proposed solution combines modern clean infrastructure and research-based processes to deliver sterile and scalable biotechnological solutions in different forms of dosage. Systematic quality management and strict regulatory compliance ensure a result that supports market entry and patient safety. For whom Service is suitable for pharmaceutical companies, biotechnology start-ups, clinical trial partners and contrast manufacturers

GMP-level gene vector production: purity, stability and regulatory certainty for placing gene therapy medicinal products on the market

Overview   GMP compliant production  focuses on the production of high-quality gene vectors and gene therapy medicinal products that support both clinical trial
ssb.ee
Overview GMP compliant production focuses on the production of high-quality gene vectors and gene therapy medicinal products that support both clinical trials and commercial production. The services are designed to develop genetic treatments by providing a scalable, safe and reproducible production solution that reduces development risks and speeds up the time line to reach the market. Who benefits? The services are suitable for biotechnology companies, pharmaceutical companies, research laboratories and start-up teams that require reliable production of gen vectors for the clinical

Complete laboratory analysis and development of pharmaceutical formulations - reliable quality control and validated production processes

Connected with quality, repeatability and regulatory compliance.  Complete laboratory analysis and development of adapted pharmaceutical formulations ensure tha
ssb.ee
Connected with quality, repeatability and regulatory compliance. Complete laboratory analysis and development of adapted pharmaceutical formulations ensure that the performance and safety of the product meet both the requirements of the clinical and manufacturing environment. What service covers Provides comprehensive laboratory analysis and testing , extensive quality control and analysis and targeted medical formulations development . Work also includes the validation of production processes in order to confirm the replicability of processes and support regulatory approval.

Complete pharmaceutical production - fast pharmaceutical product development and production of biological medicinal products that meet GMP requirements

Healthy pharmaceutical production  combines scientific precision and industrial performance in order to bring drug development from the idea to the clinical pha
ssb.ee
Healthy pharmaceutical production combines scientific precision and industrial performance in order to bring drug development from the idea to the clinical phase and to the market faster and safer. The services cover the entire value chain: pharmaceutical product development, formulations, production of biological medicines and full quality control and analysis - all according to GMP compliant production . What does this mean for production and development? Integrated approach reduces transition, shorter timetables ensure lower risk and better cost-effectiveness. In combination with a

Are you sure you want to delete this article?

Loader

Loader

App Ad

Scorestorybook Chrome extension

The Storybook extension tells you which company's website you are currently on and how reliable that company is today. download extension

See the background of the caller! Storybook App brings you direct contacts for 400,000 Estonian companies and individuals (managers, officials). The data is enriched with solvency and financial information.